These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22133759)

  • 1. Lidocaine metabolites inhibit glycine transporter 1: a novel mechanism for the analgesic action of systemic lidocaine?
    Werdehausen R; Kremer D; Brandenburger T; Schlösser L; Jadasz J; Küry P; Bauer I; Aragón C; Eulenburg V; Hermanns H
    Anesthesiology; 2012 Jan; 116(1):147-58. PubMed ID: 22133759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lidocaine metabolite N-ethylglycine has antinociceptive effects in experimental inflammatory and neuropathic pain.
    Werdehausen R; Mittnacht S; Bee LA; Minett MS; Armbruster A; Bauer I; Wood JN; Hermanns H; Eulenburg V
    Pain; 2015 Sep; 156(9):1647-1659. PubMed ID: 25932687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycine transporters GlyT1 and GlyT2 are differentially modulated by glycogen synthase kinase 3β.
    Jiménez E; Núñez E; Ibáñez I; Zafra F; Aragón C; Giménez C
    Neuropharmacology; 2015 Feb; 89():245-54. PubMed ID: 25301276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDNF, via truncated TrkB receptor, modulates GlyT1 and GlyT2 in astrocytes.
    Aroeira RI; Sebastião AM; Valente CA
    Glia; 2015 Dec; 63(12):2181-97. PubMed ID: 26200505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phosphatidylinositol 3-kinase inhibitor LY 294002 inhibits GlyT1-mediated glycine uptake.
    Wu ZL; O'Kane TM; Connors TJ; Marino MJ; Schaffhauser H
    Brain Res; 2008 Aug; 1227():42-51. PubMed ID: 18621031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
    Depoortère R; Dargazanli G; Estenne-Bouhtou G; Coste A; Lanneau C; Desvignes C; Poncelet M; Heaulme M; Santucci V; Decobert M; Cudennec A; Voltz C; Boulay D; Terranova JP; Stemmelin J; Roger P; Marabout B; Sevrin M; Vigé X; Biton B; Steinberg R; Françon D; Alonso R; Avenet P; Oury-Donat F; Perrault G; Griebel G; George P; Soubrié P; Scatton B
    Neuropsychopharmacology; 2005 Nov; 30(11):1963-85. PubMed ID: 15956994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GlyT1 and GlyT2 in brain astrocytes: expression, distribution and function.
    Aroeira RI; Sebastião AM; Valente CA
    Brain Struct Funct; 2014 May; 219(3):817-30. PubMed ID: 23529192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the local anesthetics lidocaine and procaine on glycine and gamma-aminobutyric acid receptors expressed in Xenopus oocytes.
    Hara K; Sata T
    Anesth Analg; 2007 Jun; 104(6):1434-9, table of contents. PubMed ID: 17513637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleoyl-L-carnitine inhibits glycine transport by GlyT2.
    Carland JE; Mansfield RE; Ryan RM; Vandenberg RJ
    Br J Pharmacol; 2013 Feb; 168(4):891-902. PubMed ID: 22978602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupivacaine reduces GlyT1 expression by potentiating the p-AMPKα/BDNF signalling pathway in spinal astrocytes of rats.
    Lu K; Zhao L; Zhang Y; Yang F; Zhang H; Wang J; Li B; Ji G; Yu J; Ma H
    Sci Rep; 2022 Jan; 12(1):1378. PubMed ID: 35082359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular identification and characterisation of the glycine transporter (GLYT1) and the glutamine/glutamate transporter (ASCT2) in the rat lens.
    Lim J; Lorentzen KA; Kistler J; Donaldson PJ
    Exp Eye Res; 2006 Aug; 83(2):447-55. PubMed ID: 16635486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of the inhibitory neurotransmitter transporters GlyT1, GAT-1, and GAT-3 in astrocytes of the lateral superior olive.
    Stephan J; Friauf E
    Glia; 2014 Dec; 62(12):1992-2003. PubMed ID: 25103283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional 'glial' GLYT1 glycine transporters expressed in neurons.
    Raiteri L; Raiteri M
    J Neurochem; 2010 Aug; 114(3):647-53. PubMed ID: 20477934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of release-regulating glycine transporters GLYT1 on GABAergic neurons and GLYT2 on astrocytes in mouse spinal cord.
    Raiteri L; Stigliani S; Usai C; Diaspro A; Paluzzi S; Milanese M; Raiteri M; Bonanno G
    Neurochem Int; 2008 Jan; 52(1-2):103-12. PubMed ID: 17597258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of functional inhibitory neurotransmitter transporters GlyT1, GAT-1, and GAT-3 by astrocytes of inferior colliculus and hippocampus.
    Ghirardini E; Wadle SL; Augustin V; Becker J; Brill S; Hammerich J; Seifert G; Stephan J
    Mol Brain; 2018 Jan; 11(1):4. PubMed ID: 29370841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport activities and expression patterns of glycine transporters 1 and 2 in the developing murine brain stem and spinal cord.
    Lall D; Armbruster A; Ruffert K; Betz H; Eulenburg V
    Biochem Biophys Res Commun; 2012 Jul; 423(4):661-6. PubMed ID: 22695116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term application of glycine transporter inhibitors acts antineuropathic and modulates spinal N-methyl-D-aspartate receptor subunit NR-1 expression in rats.
    Barthel F; Urban A; Schlösser L; Eulenburg V; Werdehausen R; Brandenburger T; Aragon C; Bauer I; Hermanns H
    Anesthesiology; 2014 Jul; 121(1):160-9. PubMed ID: 24598217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.
    Núñez E; Martínez-Maza R; Geerlings A; Aragón C; López-Corcuera B
    Neuropharmacology; 2005 Nov; 49(6):922-34. PubMed ID: 16143353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALX 1393 inhibits spontaneous network activity by inducing glycinergic tonic currents in the spinal ventral horn.
    Eckle VS; Antkowiak B
    Neuroscience; 2013 Dec; 253():165-71. PubMed ID: 23994185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.